FAM83A (NM_032899) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC208565L4V
- LentiORF®
-
Lenti ORF particles, FAM83A (mGFP-tagged) - Human family with sequence similarity 83, member A (FAM83A), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 9,975.00
货期*
详询
规格
Cited in 1 publication. |
经常一起买 (3)
Specifications
Product Data | |
Product Name | FAM83A (NM_032899) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | BJ-TSA-9 |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | NM_032899 |
ORF Size | 1302 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC208565).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_032899.4, NP_116288.2 |
RefSeq Size | 4596 bp |
RefSeq ORF | 1305 bp |
Locus ID | 84985 |
MW | 47.5 kDa |
Gene Summary | Probable proto-oncogene that functions in the epidermal growth factor receptor/EGFR signaling pathway. Activates both RAS/MAPK and PI3K/AKT/TOR signaling cascades downstream of EGFR. Required for the RAS/MAPK signaling cascade activation upon EGFR stimulation, it also activates both signaling cascades independently of EGFR activation.[UniProtKB/Swiss-Prot Function] |
Citations (1)
The use of this cDNA Clones has been cited in the following citations: |
---|
FAM83A is a potential biomarker for breast cancer initiation
,null,
Biomarker Research
,PubMed ID 35183258
[FAM83A]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...